6550--STX Cepheid Reagents - IDIQ

SOL #: 36C25726Q0244Award Notice

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
257-NETWORK CONTRACT OFFICE 17 (36C257)
San Antonio, TX, 78240, United States

Place of Performance

Place of performance not available

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Jan 20, 2026
2
Last Updated
Apr 2, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), Network Contracting Office 17, has awarded a sole-source contract to Cepheid for STX Cepheid Reagents and consumable supplies. This award, valued at $714,452.55, supports the South Texas Veterans Health Care System (STVHCS) Microbiology Department for Ordering Period 1. The contract was awarded on April 2, 2026, under the authority of FAR 6.103-1.

Scope of Work

This contract procures brand-name reagent kits and consumable supplies specifically designed for the Leased Cepheid Gene Xpert Infinity instruments at the Audie L. Murphy VA Hospital. Key requirements include a variety of diagnostic reagents such as those for Flu, TB, C. Diff, MRSA, and other related testing. The vendor, Cepheid, is required to provide ready-to-use reagents on an "as needed" basis and must be an authorized distributor. Performance standards include 24-hour order confirmation, tracking information, and prompt fulfillment of emergency orders.

Contract Details

  • Awardee: Cepheid (UEI: W6HQTMWB9Q28)
  • Award Amount: $714,452.55
  • Award Date: April 2, 2026
  • Contract Type: Sole Source (IDIQ)
  • Period of Performance: Base year from April 12, 2026, to April 11, 2027, with potential for 4 option years.
  • Place of Performance: Microbiology Laboratory, Pathology and Laboratory Medicine Service, San Antonio Laboratories of the STVHCS.
  • NAICS Code: 325413 (In-Vitro Diagnostic Substance Manufacturing)
  • Product Service Code: 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets)

Set-Aside

None (Sole Source Award). Prior market research for this requirement noted that interested Service Disabled Veteran Owned Small Businesses (SDVOSB) and Veteran Owned Small Businesses (VOSB) would need to be verified on the SBA Small Business Search database.

Additional Notes

This award follows a Special Notice of Intent to Sole Source (36C25726Q0244) published on January 20, 2026. The VA conducted market research, and responsible sources were invited to submit capability statements by February 2, 2025, to challenge the sole source justification. No competitive proposals were requested for this specific award.

People

Points of Contact

Jose CampaContracting OfficerPRIMARY

Files

Files

Download
Download

Versions

Version 3
Award Notice
Posted: Apr 2, 2026
View
Version 2Viewing
Award Notice
Posted: Apr 2, 2026
Version 1
Special Notice
Posted: Jan 20, 2026
View
6550--STX Cepheid Reagents - Ordering Period 1 | GovScope